FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda, Hem Securities, Nirmal Bang and InvestorGain.com have given "Apply" recommendation to Tarsons Products IPO. Capital Market has given "May Apply" recommendation to Tarsons Products IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 4 | 1 | 0 | 0 | 0 |
% | 80.00 | 20.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Capital Market | May Apply | |
Dilip Davda | Apply | |
Hem Securities | Apply | |
Nirmal Bang | Apply | |
InvestorGain.com | Apply |
The Captial Market (CapitalMarket.com) rating for Tarsons Products IPO is 45. Their analysis recommends May subscribe for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 45 | May subscribe |
[Dilip Davda] TPL is the second-largest player in plastic labware and post-pandemic, due to rising concerns for health, this company is poised for bright prospects ahead. It is expanding to meet the rising demand for its products. The issue appears reasonably priced based on its financial data and future prospects. TPL is enhancing its role and expanding its product portfolio. The scrip is expected to generate first-mover fancy post listing, Investors may consider investment for the medium to long term rewards. Read detail review...
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|